MedTrace Logo

Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

NCT00492895 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-01-29

No results posted yet for this study

Summary

Photosensitivity of the skin to UVA and UVB will be determined

Conditions

Interventions

DRUG

Discontinuation of Azathioprin

Discontinuation of Azathioprin

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Günther Hofbauer, M.D · UniversitaetsSpital Zuerich

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2010-12-31
Completion
2011-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00492895 on ClinicalTrials.gov